Sphingosine‐1‐Phosphate Receptor 3 Confers Tumor Metastasis in Lung Cancer Resistant to Third‐Generation EGFR Inhibitor

Ähnliche Einträge

• Persistent Activation of Sphingosine‐1‐Phosphate Receptor 1 by Phytosphingosine‐3,4‐Cyclic Phosphate Ameliorates Sepsis by Inhibiting Hyperinflammation and Vascular Hyperpermeability
  von: Suhong Duan, et al.
  Veröffentlicht: (2025)
• First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
  von: Wei Du, et al.
  Veröffentlicht: (2025)
• Progression and Metastasis of Lung Cancer: Clinical Features, Molecular Mechanisms, and Clinical Managements
  von: Yunkui Zhang, et al.
  Veröffentlicht: (2025)
• Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors
  von: Zhonghan Zhang, et al.
  Veröffentlicht: (2024)
• Traditional Chinese Medicine Modernization in Diagnosis and Treatment: Utilizing Artificial Intelligence and Nanotechnology
  von: Wenqi Yu, et al.
  Veröffentlicht: (2026)